HSPB1 and urinary bladder cancer: To further elucidate the downstream mechanism, we utilized KRIBB3, an inhibitor of HSP27, to validate its inhibitory effect on HSP27 in bladder cancer cells, confirming its suitability for subsequent experiments (Figure 6E, F).